SYSTEM AND METHOD FOR AUTOMATED PREDICTION OF VULNERABILITIES IN BIOLOGICAL SAMPLES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

14894138

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

In order to exploit vulnerabilities of cancer cells on the basis of homozygous deletion, a genomic profile of cancer cells in a biological sample is analyzed to identify homozygous deletions of one or more genes. The homozygous deletions, in turn, are analyzed in view of pathway data (e.g., metabolic, signaling, and/or cell-to-cell communication pathway data obtained from one or more databases) to determine a subset of homozygous deletions performing a function important to the viability of the cell. From this subset of homozygous deletions, cellular pathway data is analyzed to identify one or more partner genes (e.g., synthetic lethals) considered to facilitate or perform the same or similar function as the respective homozygous deletion. Drug annotations, in turn, may be reviewed to identify drugs that inhibit at least one of the synthetic lethal genes and/or gene products.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEMORIAL SLOAN-KETTERING CANCER CENTER1275 YORK AVENUE NEW YORK NY 10065

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
AKSOY, Bulent Arman New York, US 1 0
SANDER, Chris New York, US 9 27

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation